Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles E Inturrisi

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
Pain|April 1, 1995
Morphine-6-glucuronide concentrations and opioid-related side effects: a survey in cancer patientsPaul J Tiseo, Howard T Thaler, Jeanne Lapin, et al.
Brain Research. Molecular Brain Research|October 16, 2003
MK-801 attenuates cocaine induction of c-fos and preprodynorphin mRNA levels in Fischer ratsShirzad Jenab, Eugene D Festa, Scott J Russo, et al.
The American Journal on Addictions|September 25, 2018
Naltrexone Maintenance: Effect on Morphine Sensitivity in Normal VolunteersJames W Cornish, David Henson, Sanford Levine, et al.
The Journal of Pain|January 16, 2017
Patient-Reported Outcomes and Opioid Use in Outpatients With Chronic PainLisa R Witkin, David Zylberger, Neel Mehta, et al.
Cancer Medicine|October 1, 2019
Does transdermal fentanyl work in patients with low BMI? Patient-reported outcomes of pain and percent pain relief in cancer patients on transdermal fentanylNatalie Moryl, Ali Bokhari, Yvona Griffo, et al.
Pain Management|June 9, 2021
The effect of obesity on pain severity and pain interferenceJade I Basem, Robert S White, Stephanie A Chen, et al.
Pain|November 1, 1985
The analgesic efficacy of intrathecal D-Ala2-D-Leu5-enkephalin in cancer patients with chronic painDwight E Moulin, Mitchell B Max, Robert F Kaiko, et al.
Pain|October 1, 1991
Plasma morphine and morphine-6-glucuronide during chronic morphine therapy for cancer pain: plasma profiles, steady-state concentrations and the consequences of renal failureRussell K Portenoy, Kathleen M Foley, James Stulman, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 30, 2008
Deletion of the glutamate receptor 5 subunit of kainate receptors affects the development of morphine toleranceJohanna J Bogulavsky, Ann M Gregus, Paul T-H Kim, et al.
Experimental Neurology|July 11, 2008
Conditional deletion of the NMDA-NR1 receptor subunit gene in the central nucleus of the amygdala inhibits naloxone-induced conditioned place aversion in morphine-dependent miceMichael J Glass, Deborah M Hegarty, Martin Oselkin, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Pain|April 1, 1995
Morphine-6-glucuronide concentrations and opioid-related side effects: a survey in cancer patientsPaul J Tiseo, Howard T Thaler, Jeanne Lapin, et al.
Brain Research. Molecular Brain Research|October 16, 2003
MK-801 attenuates cocaine induction of c-fos and preprodynorphin mRNA levels in Fischer ratsShirzad Jenab, Eugene D Festa, Scott J Russo, et al.
The American Journal on Addictions|September 25, 2018
Naltrexone Maintenance: Effect on Morphine Sensitivity in Normal VolunteersJames W Cornish, David Henson, Sanford Levine, et al.
The Journal of Pain|January 16, 2017
Patient-Reported Outcomes and Opioid Use in Outpatients With Chronic PainLisa R Witkin, David Zylberger, Neel Mehta, et al.
Cancer Medicine|October 1, 2019
Does transdermal fentanyl work in patients with low BMI? Patient-reported outcomes of pain and percent pain relief in cancer patients on transdermal fentanylNatalie Moryl, Ali Bokhari, Yvona Griffo, et al.
Pain Management|June 9, 2021
The effect of obesity on pain severity and pain interferenceJade I Basem, Robert S White, Stephanie A Chen, et al.
Pain|November 1, 1985
The analgesic efficacy of intrathecal D-Ala2-D-Leu5-enkephalin in cancer patients with chronic painDwight E Moulin, Mitchell B Max, Robert F Kaiko, et al.
Pain|October 1, 1991
Plasma morphine and morphine-6-glucuronide during chronic morphine therapy for cancer pain: plasma profiles, steady-state concentrations and the consequences of renal failureRussell K Portenoy, Kathleen M Foley, James Stulman, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 30, 2008
Deletion of the glutamate receptor 5 subunit of kainate receptors affects the development of morphine toleranceJohanna J Bogulavsky, Ann M Gregus, Paul T-H Kim, et al.
Experimental Neurology|July 11, 2008
Conditional deletion of the NMDA-NR1 receptor subunit gene in the central nucleus of the amygdala inhibits naloxone-induced conditioned place aversion in morphine-dependent miceMichael J Glass, Deborah M Hegarty, Martin Oselkin, et al.
Pageof 7